Key Client Fiduciary Advisors’s Johnson & Johnson JNJ Stock Holding History

Key Client Fiduciary Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$738K	Buy	2,907 +501	+21%	+$117K	0.21%	95
2026 Q1	$588K	Sell	2,406 -66	-3%	-$15.4K	0.2%	107
2025 Q4	$511K	Sell	2,472 -268	-10%	-$53K	0.17%	115
2025 Q3	$508K	Sell	2,740 -34	-1%	-$5.83K	0.17%	115
2025 Q2	$424K	Sell	2,774 -1,033	-27%	-$159K	0.17%	122
2025 Q1	$631K	Sell	3,807 -67	-2%	-$10.5K	0.29%	84
2024 Q4	$560K	Sell	3,874 -88	-2%	-$13.6K	0.25%	94
2024 Q3	$642K	Buy	3,962 +58	+1%	+$9.24K	0.29%	80
2024 Q2	$571K	Sell	3,904 -399	-9%	-$59.3K	0.28%	83
2024 Q1	$681K	Buy	4,303 +357	+9%	+$56.8K	0.36%	64
2023 Q4	$619K	Sell	3,946 -536	-12%	-$82.2K	0.36%	67
2023 Q3	$698K	Sell	4,482 -274	-6%	-$45.2K	0.43%	56
2023 Q2	$787K	Buy	4,756 +163	+4%	+$26.3K	0.46%	47
2023 Q1	$712K	Sell	4,593 -17	-0.4%	-$2.75K	0.44%	50
2022 Q4	$814K	Buy	4,610 +2,092	+83%	+$361K	0.55%	41
2022 Q3	$411K	Buy	2,518 +2	+0.1%	+$338	0.37%	56
2022 Q2	$447K	Buy	2,516 +398	+19%	+$70.9K	0.44%	52
2022 Q1	$375K	Buy	2,118 +741	+54%	+$126K	0.3%	83
2021 Q4	$236K	Buy	+1,377	New	+$225K	0.19%	109

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Key Client Fiduciary Advisors's JNJ Position: Q2 2026 in Review

Key Client Fiduciary Advisors increased its Johnson & Johnson (JNJ) stake by 21% in Q2 2026, buying an estimated $117K and bringing the position to 2,907 shares worth $738K. The position accounts for 0.21% of the portfolio, ranked #95.

Key Client Fiduciary Advisors first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $814K in Q4 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Key Client Fiduciary Advisors held 2,907 shares of Johnson & Johnson worth $738K as of Q2 2026.
Key Client Fiduciary Advisors bought 501 Johnson & Johnson shares in Q2 2026, an estimated $117K.
Johnson & Johnson made up 0.21% of Key Client Fiduciary Advisors's portfolio in Q2 2026, its #95 holding.
Key Client Fiduciary Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
Key Client Fiduciary Advisors's Johnson & Johnson position peaked at $814K in Q4 2022.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Key Client Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.